Halozyme
HALO
198 hedge funds and large institutions have $2.48B invested in Halozyme in 2017 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 72 increasing their positions, 54 reducing their positions, and 14 closing their positions.
229% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 14
148% more call options, than puts
Call options by funds: $62M | Put options by funds: $24.9M
33% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 54
19% more funds holding
Funds holding: 166 → 198 (+32)
18% more capital invested
Capital invested by funds: $2.11B → $2.48B (+$373M)
0.46% more ownership
Funds ownership: 85.64% → 86.1% (+0.46%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22.2M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$16.5M |
| 3 |
Renaissance Technologies
New York
|
+$13.5M |
| 4 |
Millennium Management
New York
|
+$13.5M |
| 5 |
Two Sigma Advisers
New York
|
+$10.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Senzar Asset Management
New York
|
-$60.5M |
| 2 |
First Eagle Investment Management
New York
|
-$35.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$31.6M |
| 4 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$22.6M |
| 5 |
O
OrbiMed
New York
|
-$6.08M |
HALO Hedge Fund Activity: Q4 2017 in Review
198 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2017, worth a combined $2.48B — up 18% from $2.11B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new HALO positions and 14 closed out — a net gain of 32 holders — while 72 added to existing stakes and 54 trimmed.
The largest buyer was Vanguard Group, adding an estimated $22.2M. The largest seller was Senzar Asset Management, cutting an estimated $60.5M.
- 198 institutional investors held Halozyme (HALO) as of Q4 2017, up from 166 in Q3 2017.
- Funds reported $2.48B of Halozyme stock for Q4 2017, up 18% quarter-over-quarter.
- 46 funds opened new Halozyme positions in Q4 2017 and 14 closed out, a net change of +32 holders.
- The largest Halozyme buyer in Q4 2017 was Vanguard Group, an estimated $22.2M added.
- The largest Halozyme seller in Q4 2017 was Senzar Asset Management, an estimated $60.5M sold.
Based on aggregated 13F filings for Q4 2017.